Anne Wallace

Title(s)Professor Of Clinical, Surgery
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Research Overview
    Dr. Wallace employs nuclear and fluorescence imaging to detect and stage melanoma and breast cancer. She also employs advanced imaging techniques to study stem cell reconstructive surgery.

    Research Topics
    - Cancer
    - Regeneration/Stem Cells

    Current Project Titles
    - Stem Cell Tracking after Reconstructive Surgery
    - Fluorescence Detection of Breast Cancer
    - Sentinel Lymph Node Mapping via Fluorescence Detection

    Profile
    Dr. Anne Wallace is a member of both the Division of General Surgery and the Division of Plastic Surgery. She has directed the breast program since 1995 at the UC San Diego Moores Cancer Center. The Breast Care Unit is a team of doctors, nurses, researchers, and other health professionals who work closely together to provide excellent care and the latest available treatments for patients who have breast cancer.

    Dr. Wallace participates in the Translational Oncology Program at the UC San Diego Moores Cancer Center. In her research, Dr. Wallace studies the causes, behavior, and treatment of breast cancer and melanoma. Her special research interests include breast cancer prevention and the improvement of techniques for sentinel lymph node biopsy. She is an investigator in the ongoing National Surgical Adjuvant Breast and Bowel Project (NSABP) study of breast cancer treatments as well as several other studies. She also collaborates with basic science researchers to develop new ways to detect breast cancer early and to identify individuals who are at higher risk for developing the disease.

    Dr. Wallace holds leadership positions in several national and local cancer organizations, including the American Cancer Society, the American Melanoma Society, and the California Breast Cancer Research Council. She has served as Vice President of Cancer Control for the Golden Triangle Division of the American Cancer Society and as Chairman of the California Breast Cancer Research Council.

    In 1999, the Komen Foundation honored Dr. Wallace as Breast Cancer Clinician of the Year. She was named the Clinical Teacher of the Year for 2000 in the UC San Diego Division of Plastic Surgery.

    Collapse Research 
    Collapse research activities and funding
    A New Radiotracer for Prostate Sentinel Node Mapping
    NIH R21CA112940May 19, 2006 - Apr 30, 2010
    Role: Principal Investigator
    A Phase II Study of a New Sentinel Node Radiotracer
    NIH R21CA097643Sep 24, 2002 - Aug 31, 2005
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Adhesion strength of tumor cells predicts metastatic disease in vivo. Cell Rep. 2025 Mar 25; 44(3):115359. Kane MA, Birmingham KG, Yeoman B, Patel N, Sperinde H, Molley TG, Beri P, Tuler J, Kumar A, Klein S, Zare S, Wallace A, Katira P, Engler AJ. PMID: 40049163; PMCID: PMC12014391.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial. Ann Surg Oncol. 2025 May; 32(5):3278-3291. Boughey JC, Yu H, Switalla K, Velle L, Lopes A, Wallace AM, Lancaster RB, Reyna CR, Tuttle TM, Jaskowiak N, Tchou J, Rao R, Lee MC, Naik AM, Golshan M, Arciero CA, Sauder CAM, Matsen CB, Yau C, Esserman L, Mukhtar RA, I-SPY2 Locoregional Working Group. PMID: 39946078.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for postoperative analgesia: A randomized, double-masked, sham-controlled pilot study. Pain Pract. 2025 Feb; 25(2):e70007. Ilfeld BM, Finneran JJ, Said ET, Ball ST, Wallace AM, Broderick RC, Sandler BJ, Doucet JJ, Hu SR, Cha BJ, Murthy AN, Abdullah B. PMID: 39829429; PMCID: PMC11744435.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer. Breast Cancer Res Treat. 2025 Feb; 209(3):487-492. Rugo HS, Campbell M, Yau C, Jo Chien A, Wallace AM, Isaacs C, Boughey JC, Han HS, Buxton M, Clennell JL, Asare SM, Steeg K, Wilson A, Singhrao R, Matthews JB, Perlmutter J, Fraser Symmans W, Hylton NM, DeMichele AM, Yee D, Van't Veer LJ, Berry DA, Esserman LJ. PMID: 39625569; PMCID: PMC11785665.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Paravertebral versus Pectoralis-II (Interpectoral and Pectoserratus) Nerve Blocks for Postoperative Analgesia after Nonmastectomy Breast Surgery: A Randomized, Controlled, Observer-masked Noninferiority Trial. Anesthesiology. 2024 Dec 01; 141(6):1039-1050. Gabriel RA, Curran BP, Swisher MW, Sztain JF, Tsuda PS, Said ET, Alexander B, Finneran JJ, Abramson WB, Black JR, Wallace AM, Blair S, Donohue MC, Abdullah B, Xu NY, Cha BJ, Ilfeld BM. PMID: 39186671.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3728-3736. Khoury K, Meisel JL, Yau C, Rugo HS, Nanda R, Davidian M, Tsiatis B, Chien AJ, Wallace AM, Arora M, Rozenblit M, Hershman DL, Zimmer A, Clark AS, Beckwith H, Elias AD, Stringer-Reasor E, Boughey JC, Nangia C, Vaklavas C, Omene C, Albain KS, Kalinsky KM, Isaacs C, Tseng J, Roussos Torres ET, Thomas B, Thomas A, Sanford A, Balassanian R, Ewing C, Yeung K, Sauder C, Sanft T, Pusztai L, Trivedi MS, Outhaythip A, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Fraser Symmans W, Price E, Beedle C, Perlmutter J, Pohlmann P, Shatsky RA, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. PMID: 39277671; PMCID: PMC12044543.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    7. Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3737-3747. Shatsky RA, Trivedi MS, Yau C, Nanda R, Rugo HS, Davidian M, Tsiatis B, Wallace AM, Chien AJ, Stringer-Reasor E, Boughey JC, Omene C, Rozenblit M, Kalinsky K, Elias AD, Vaklavas C, Beckwith H, Williams N, Arora M, Nangia C, Roussos Torres ET, Thomas B, Albain KS, Clark AS, Falkson C, Hershman DL, Isaacs C, Thomas A, Tseng J, Sanford A, Yeung K, Boles S, Chen YY, Huppert L, Jahan N, Parker C, Giridhar K, Howard FM, Blackwood MM, Sanft T, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Symmans WF, Price E, Heditsian D, LeStage B, Perlmutter J, Pohlmann P, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. PMID: 39277672; PMCID: PMC12089997.
      View in: PubMed   Mentions: 7     Fields:    Translation:CTClinical Trials
    8. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7249-7259. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA. PMID: 38995451; PMCID: PMC11452431.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Distance of Biopsy-Confirmed High-Risk Breast Lesion from Concurrently Identified Breast Malignancy Associated with Risk of Carcinoma at the High-Risk Lesion Site. Cancers (Basel). 2024 Jun 19; 16(12). Le J, O'Keefe TJ, Khan S, Grossi SM, Choi HY, Ojeda-Fournier H, Armani A, Wallace AM, Blair SL. PMID: 38927976; PMCID: PMC11201489.
      View in: PubMed   Mentions:
    10. Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clin Cancer Res. 2024 02 16; 30(4):729-740. Albain KS, Yau C, Petricoin EF, Wolf DM, Lang JE, Chien AJ, Haddad T, Forero-Torres A, Wallace AM, Kaplan H, Pusztai L, Euhus D, Nanda R, Elias AD, Clark AS, Godellas C, Boughey JC, Isaacs C, Tripathy D, Lu J, Yung RL, Gallagher RI, Wulfkuhle JD, Brown-Swigart L, Krings G, Chen YY, Potter DA, Stringer-Reasor E, Blair S, Asare SM, Wilson A, Hirst GL, Singhrao R, Buxton M, Clennell JL, Sanil A, Berry S, Asare AL, Matthews JB, DeMichele AM, Hylton NM, Melisko M, Perlmutter J, Rugo HS, Symmans WF, Van't Veer LJ, Yee D, Berry DA, Esserman LJ. PMID: 38109213; PMCID: PMC10956403.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    11. Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers. Res Sq. 2024 Jan 11. O'Keefe T, Wallace A, Hirst G, Yau C, Esserman L, Iaconetti E, Brabham C, Kim P, Harismendy O, Jeong E, McGuire J, Griffin A. PMID: 38260526; PMCID: PMC10802747.
      View in: PubMed   Mentions:
    12. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer. JAMA Netw Open. 2023 12 01; 6(12):e2349646. Kyalwazi B, Yau C, Campbell MJ, Yoshimatsu TF, Chien AJ, Wallace AM, Forero-Torres A, Pusztai L, Ellis ED, Albain KS, Blaes AH, Haley BB, Boughey JC, Elias AD, Clark AS, Isaacs CJ, Nanda R, Han HS, Yung RL, Tripathy D, Edmiston KK, Viscusi RK, Northfelt DW, Khan QJ, Asare SM, Wilson A, Hirst GL, Lu R, Symmans WF, Yee D, DeMichele AM, van 't Veer LJ, Esserman LJ, Olopade OI. PMID: 38153734; PMCID: PMC10755617.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    13. Restriction spectrum imaging with elastic image registration for automated evaluation of response to neoadjuvant therapy in breast cancer. Front Oncol. 2023; 13:1237720. Andreassen MMS, Loubrie S, Tong MW, Fang L, Seibert TM, Wallace AM, Zare S, Ojeda-Fournier H, Kuperman J, Hahn M, Jerome NP, Bathen TF, Rodríguez-Soto AE, Dale AM, Rakow-Penner R. PMID: 37781199; PMCID: PMC10541212.
      View in: PubMed   Mentions: 1  
    14. Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy. JAMA Surg. 2023 06 01; 158(6):674-675. O'Keefe TJ, Wallace AM. PMID: 36811893.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial. Breast Cancer Res Treat. 2023 Jun; 199(2):281-291. Parker BA, Shatsky RA, Schwab RB, Wallace AM, I-SPY 2 Consortium, Wolf DM, Hirst GL, Brown-Swigart L, Esserman LJ, van 't Veer LJ, Ghia EM, Yau C, Kipps TJ. PMID: 37029329; PMCID: PMC10175386.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. Bilateral mastectomy associated with higher breast cancer mortality among patients with estrogen receptor positive progesterone receptor negative localized breast cancer. Chin Clin Oncol. 2023 Feb; 12(1):3. O'Keefe TJ, Harismendy O, Wallace AM. PMID: 36922359.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study. Breast Cancer Res Treat. 2023 Apr; 198(2):383-390. Magbanua MJM, van 't Veer L, Clark AS, Chien AJ, Boughey JC, Han HS, Wallace A, Beckwith H, Liu MC, Yau C, Wileyto EP, Ordonez A, Solanki TI, Hsiao F, Lee JC, Basu A, Brown Swigart L, Perlmutter J, Delson AL, Bayne L, Deluca S, Yee SS, Carpenter EL, Esserman LJ, Park JW, Chodosh LA, DeMichele A. PMID: 36689092; PMCID: PMC10290540.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for analgesia and opioid sparing following outpatient surgery: A proof-of-concept case series. Pain Pract. 2023 06; 23(5):553-558. Ilfeld BM, Said ET, Gabriel RA, Curran BP, Swisher MW, Jacobsen GR, Wallace AM, Doucet J, Adams LM, Ventro GJ, Abdullah B, Finneran JJ. PMID: 36463434.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer. NPJ Breast Cancer. 2022 Dec 01; 8(1):128. Lang JE, Forero-Torres A, Yee D, Yau C, Wolf D, Park J, Parker BA, Chien AJ, Wallace AM, Murthy R, Albain KS, Ellis ED, Beckwith H, Haley BB, Elias AD, Boughey JC, Yung RL, Isaacs C, Clark AS, Han HS, Nanda R, Khan QJ, Edmiston KK, Stringer-Reasor E, Price E, Joe B, Liu MC, Brown-Swigart L, Petricoin EF, Wulfkuhle JD, Buxton M, Clennell JL, Sanil A, Berry S, Asare SM, Wilson A, Hirst GL, Singhrao R, Asare AL, Matthews JB, Melisko M, Perlmutter J, Rugo HS, Symmans WF, van 't Veer LJ, Hylton NM, DeMichele AM, Berry DA, Esserman LJ. PMID: 36456573; PMCID: PMC9715670.
      View in: PubMed   Mentions: 8  
    20. Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence. Surgery. 2023 02; 173(2):305-311. O'Keefe TJ, Chau H, Harismendy O, Wallace AM. PMID: 36435650.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Localizing Positive Axillary Lymph Nodes in Breast Cancer Patients Post Neoadjuvant Therapy. J Surg Res. 2023 Mar; 283:288-295. Taj R, Chung SH, Goldhaber NH, Louie BH, Marganski JG, Grewal NS, Rane ZS, Ojeda-Fournier H, Armani A, Wallace A, Blair SL. PMID: 36423478.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    22. Preoperative Ultrasound-guided Percutaneous Cryoneurolysis for the Treatment of Pain after Mastectomy: A Randomized, Participant- and Observer-masked, Sham-controlled Study. Anesthesiology. 2022 11 01; 137(5):529-542. Ilfeld BM, Finneran JJ, Swisher MW, Said ET, Gabriel RA, Sztain JF, Khatibi B, Armani A, Trescot A, Donohue MC, Schaar A, Wallace AM. PMID: 35929983.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. JAMA Surg. 2022 11 01; 157(11):1034-1041. Osdoit M, Yau C, Symmans WF, Boughey JC, Ewing CA, Balassanian R, Chen YY, Krings G, Wallace AM, Zare S, Fadare O, Lancaster R, Wei S, Godellas CV, Tang P, Tuttle TM, Klein M, Sahoo S, Hieken TJ, Carter JM, Chen B, Ahrendt G, Tchou J, Feldman M, Tousimis E, Zeck J, Jaskowiak N, Sattar H, Naik AM, Lee MC, Rosa M, Khazai L, Rendi MH, Lang JE, Lu J, Tawfik O, Asare SM, Esserman LJ, Mukhtar RA. PMID: 36069821; PMCID: PMC9453630.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Tri-Compartmental Restriction Spectrum Imaging Breast Model Distinguishes Malignant Lesions from Benign Lesions and Healthy Tissue on Diffusion-Weighted Imaging. Cancers (Basel). 2022 06 30; 14(13). Besser AH, Fang LK, Tong MW, Andreassen MMS, Ojeda-Fournier H, Conlin CC, Loubrie S, Seibert TM, Hahn ME, Kuperman JM, Wallace AM, Dale AM, Rodríguez-Soto AE, Rakow-Penner RA. PMID: 35804972; PMCID: PMC9264763.
      View in: PubMed   Mentions: 2  
    25. Percutaneous auricular nerve stimulation (neuromodulation) for the treatment of pain following outpatient surgery: a proof-of-concept case series. Reg Anesth Pain Med. 2022 Jun 17. Ilfeld BM, Finneran Iv JJ, Dalstrom D, Wallace AM, Abdullah B, Said ET. PMID: 35715011; PMCID: PMC9340022.
      View in: PubMed   Mentions: 4     Fields:    
    26. Retrospective review of three-fractioned accelerated partial breast irradiation. Brachytherapy. 2022 Jul-Aug; 21(4):487-493. Simon LE, Scanderbeg D, Einck J, Mayadev J, Brown D, Wallace A, Blair S, Yashar C, Huynh-Le MP. PMID: 35428569.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Predictive Analytics for Inpatient Postoperative Opioid Use in Patients Undergoing Mastectomy. Cureus. 2022 Mar; 14(3):e23079. Dolendo IM, Wallace AM, Armani A, Waterman RS, Said ET, Gabriel RA. PMID: 35464574; PMCID: PMC9001875.
      View in: PubMed   Mentions: 3  
    28. Histopathological growth distribution of ductal carcinoma in situ: tumor size is not "one size fits all". Gland Surg. 2022 Feb; 11(2):307-318. O'Keefe TJ, Harismendy O, Wallace AM. PMID: 35284308; PMCID: PMC8899433.
      View in: PubMed   Mentions: 2  
    29. Characterization of the diffusion signal of breast tissues using multi-exponential models. Magn Reson Med. 2022 04; 87(4):1938-1951. Rodríguez-Soto AE, Andreassen MMS, Fang LK, Conlin CC, Park HH, Ahn GS, Bartsch H, Kuperman J, Vidic I, Ojeda-Fournier H, Wallace AM, Hahn M, Seibert TM, Jerome NP, Østlie A, Bathen TF, Goa PE, Rakow-Penner R, Dale AM. PMID: 34904726; PMCID: PMC9148547.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial. Nat Commun. 2021 11 05; 12(1):6428. Clark AS, Yau C, Wolf DM, Petricoin EF, van 't Veer LJ, Yee D, Moulder SL, Wallace AM, Chien AJ, Isaacs C, Boughey JC, Albain KS, Kemmer K, Haley BB, Han HS, Forero-Torres A, Elias A, Lang JE, Ellis ED, Yung R, Tripathy D, Nanda R, Wulfkuhle JD, Brown-Swigart L, Gallagher RI, Helsten T, Roesch E, Ewing CA, Alvarado M, Crane EP, Buxton M, Clennell JL, Paoloni M, Asare SM, Wilson A, Hirst GL, Singhrao R, Steeg K, Asare A, Matthews JB, Berry S, Sanil A, Melisko M, Perlmutter J, Rugo HS, Schwab RB, Symmans WF, Hylton NM, Berry DA, Esserman LJ, DeMichele AM. PMID: 34741023; PMCID: PMC8571284.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    31. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. JAMA Oncol. 2021 Nov 01; 7(11):1654-1663. Symmans WF, Yau C, Chen YY, Balassanian R, Klein ME, Pusztai L, Nanda R, Parker BA, Datnow B, Krings G, Wei S, Feldman MD, Duan X, Chen B, Sattar H, Khazai L, Zeck JC, Sams S, Mhawech-Fauceglia P, Rendi M, Sahoo S, Ocal IT, Fan F, LeBeau LG, Vinh T, Troxell ML, Chien AJ, Wallace AM, Forero-Torres A, Ellis E, Albain KS, Murthy RK, Boughey JC, Liu MC, Haley BB, Elias AD, Clark AS, Kemmer K, Isaacs C, Lang JE, Han HS, Edmiston K, Viscusi RK, Northfelt DW, Khan QJ, Leyland-Jones B, Venters SJ, Shad S, Matthews JB, Asare SM, Buxton M, Asare AL, Rugo HS, Schwab RB, Helsten T, Hylton NM, van 't Veer L, Perlmutter J, DeMichele AM, Yee D, Berry DA, Esserman LJ. PMID: 34529000; PMCID: PMC8446908.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    32. Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" disease. Int J Clin Oncol. 2022 Jan; 27(1):121-130. O'Keefe TJ, Harismendy O, Wallace AM. PMID: 34618239; PMCID: PMC10874643.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer. NPJ Breast Cancer. 2021 Oct 05; 7(1):131. Yee D, Isaacs C, Wolf DM, Yau C, Haluska P, Giridhar KV, Forero-Torres A, Jo Chien A, Wallace AM, Pusztai L, Albain KS, Ellis ED, Beckwith H, Haley BB, Elias AD, Boughey JC, Kemmer K, Yung RL, Pohlmann PR, Tripathy D, Clark AS, Han HS, Nanda R, Khan QJ, Edmiston KK, Petricoin EF, Stringer-Reasor E, Falkson CI, Majure M, Mukhtar RA, Helsten TL, Moulder SL, Robinson PA, Wulfkuhle JD, Brown-Swigart L, Buxton M, Clennell JL, Paoloni M, Sanil A, Berry S, Asare SM, Wilson A, Hirst GL, Singhrao R, Asare AL, Matthews JB, Hylton NM, DeMichele A, Melisko M, Perlmutter J, Rugo HS, Fraser Symmans W, Van't Veer LJ, Berry DA, Esserman LJ. PMID: 34611148; PMCID: PMC8492731.
      View in: PubMed   Mentions: 13  
    34. ASO Author Reflections: Do Surgeon Practice Patterns Follow National Guidelines for Axillary Staging? Ann Surg Oncol. 2022 12; 29(Suppl 3):551-552. Armani A, Douglas S, Kulkarni S, Wallace A, Blair S. PMID: 34383189; PMCID: PMC9675704.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Controversial Areas in Axillary Staging: Are We Following the Guidelines? Ann Surg Oncol. 2021 Oct; 28(10):5580-5587. Armani A, Douglas S, Kulkarni S, Wallace A, Blair S. PMID: 34304312; PMCID: PMC8418590.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Serratus anterior plane versus paravertebral nerve blocks for postoperative analgesia after non-mastectomy breast surgery: a randomized controlled non-inferiority trial. Reg Anesth Pain Med. 2021 09; 46(9):773-778. Gabriel RA, Swisher MW, Sztain JF, Curran BP, Said ET, Abramson WB, Khatibi B, Alexander BS, Finneran JJ, Wallace AM, Armani A, Blair S, Dobke M, Suliman A, Reid C, Donohue MC, Ilfeld BM. PMID: 34158376; PMCID: PMC8380889.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial. Cancer Cell. 2021 07 12; 39(7):989-998.e5. Pusztai L, Yau C, Wolf DM, Han HS, Du L, Wallace AM, String-Reasor E, Boughey JC, Chien AJ, Elias AD, Beckwith H, Nanda R, Albain KS, Clark AS, Kemmer K, Kalinsky K, Isaacs C, Thomas A, Shatsky R, Helsten TL, Forero-Torres A, Liu MC, Brown-Swigart L, Petricoin EF, Wulfkuhle JD, Asare SM, Wilson A, Singhrao R, Sit L, Hirst GL, Berry S, Sanil A, Asare AL, Matthews JB, Perlmutter J, Melisko M, Rugo HS, Schwab RB, Symmans WF, Yee D, Van't Veer LJ, Hylton NM, DeMichele AM, Berry DA, Esserman LJ. PMID: 34143979; PMCID: PMC11064785.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCTClinical Trials
    38. Correction of Artifacts Induced by B0 Inhomogeneities in Breast MRI Using Reduced-Field-of-View Echo-Planar Imaging and Enhanced Reversed Polarity Gradient Method. J Magn Reson Imaging. 2021 05; 53(5):1581-1591. Rodríguez-Soto AE, Fang LK, Holland D, Zou J, Park HH, Keenan KE, Bartsch H, Kuperman J, Wallace AM, Hahn M, Ojeda-Fournier H, Dale AM, Rakow-Penner R. PMID: 33644939.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Cutaneous intralymphatic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma arising in a patient with multiple rounds of breast implants. J Cutan Pathol. 2021 May; 48(5):659-662. Wang HY, Thorson JA, Hinds BR, Swalchick W, Parker BA, Chong A, Wallace AM, Goodman AM. PMID: 33314229.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes. Breast Cancer Res Treat. 2021 Apr; 186(2):551-559. Halasz SR, O'Keefe T, Wallace AM, Blair SL. PMID: 33180236; PMCID: PMC7994183.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Discrimination of Breast Cancer from Healthy Breast Tissue Using a Three-component Diffusion-weighted MRI Model. Clin Cancer Res. 2021 02 15; 27(4):1094-1104. Andreassen MMS, Rodríguez-Soto AE, Conlin CC, Vidic I, Seibert TM, Wallace AM, Zare S, Kuperman J, Abudu B, Ahn GS, Hahn M, Jerome NP, Østlie A, Bathen TF, Ojeda-Fournier H, Goa PE, Rakow-Penner R, Dale AM. PMID: 33148675; PMCID: PMC8174004.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    42. Noncontrast MRI with advanced diffusion weighted imaging for breast cancer detection in a lactating woman. Radiol Case Rep. 2020 Nov; 15(11):2358-2361. Rodríguez-Soto AE, Meriwether CH, Park AJ, Jr DWA, Wallace A, Ojeda-Fournier H, Dale AM, Rakow-Penner R. PMID: 32994841; PMCID: PMC7502779.
      View in: PubMed   Mentions: 1  
    43. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 09 01; 6(9):1355-1362. I-SPY2 Trial Consortium, Yee D, DeMichele AM, Yau C, Isaacs C, Symmans WF, Albain KS, Chen YY, Krings G, Wei S, Harada S, Datnow B, Fadare O, Klein M, Pambuccian S, Chen B, Adamson K, Sams S, Mhawech-Fauceglia P, Magliocco A, Feldman M, Rendi M, Sattar H, Zeck J, Ocal IT, Tawfik O, LeBeau LG, Sahoo S, Vinh T, Chien AJ, Forero-Torres A, Stringer-Reasor E, Wallace AM, Pusztai L, Boughey JC, Ellis ED, Elias AD, Lu J, Lang JE, Han HS, Clark AS, Nanda R, Northfelt DW, Khan QJ, Viscusi RK, Euhus DM, Edmiston KK, Chui SY, Kemmer K, Park JW, Liu MC, Olopade O, Leyland-Jones B, Tripathy D, Moulder SL, Rugo HS, Schwab R, Lo S, Helsten T, Beckwith H, Haugen P, Hylton NM, Van't Veer LJ, Perlmutter J, Melisko ME, Wilson A, Peterson G, Asare AL, Buxton MB, Paoloni M, Clennell JL, Hirst GL, Singhrao R, Steeg K, Matthews JB, Asare SM, Sanil A, Berry SM, Esserman LJ, Berry DA. PMID: 32701140; PMCID: PMC7378873.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    44. Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis. Breast Cancer Res Treat. 2020 08; 182(3):761-762. O'Keefe TJ, Wallace AM. PMID: 32529407.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. HER2-Overexpressing Ductal Carcinoma In Situ Associated with Increased Risk of Ipsilateral Invasive Recurrence, Receptor Discordance with Recurrence. Cancer Prev Res (Phila). 2020 09; 13(9):761-772. O'Keefe TJ, Blair SL, Hosseini A, Harismendy O, Wallace AM. PMID: 32493703; PMCID: PMC7483601.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    46. Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial. JAMA Oncol. 2020 05 01; 6(5):676-684. Nanda R, Liu MC, Yau C, Shatsky R, Pusztai L, Wallace A, Chien AJ, Forero-Torres A, Ellis E, Han H, Clark A, Albain K, Boughey JC, Jaskowiak NT, Elias A, Isaacs C, Kemmer K, Helsten T, Majure M, Stringer-Reasor E, Parker C, Lee MC, Haddad T, Cohen RN, Asare S, Wilson A, Hirst GL, Singhrao R, Steeg K, Asare A, Matthews JB, Berry S, Sanil A, Schwab R, Symmans WF, van 't Veer L, Yee D, DeMichele A, Hylton NM, Melisko M, Perlmutter J, Rugo HS, Berry DA, Esserman LJ. PMID: 32053137; PMCID: PMC7058271.
      View in: PubMed   Mentions: 319     Fields:    Translation:HumansCTClinical Trials
    47. Erector spinae plane versus paravertebral nerve blocks for postoperative analgesia after breast surgery: a randomized clinical trial. Reg Anesth Pain Med. 2020 04; 45(4):260-266. Swisher MW, Wallace AM, Sztain JF, Said ET, Khatibi B, Abanobi M, Finneran Iv JJ, Gabriel RA, Abramson W, Blair SL, Hosseini A, Dobke MK, Donohue MC, Ilfeld BM. PMID: 31969443.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    48. Ultrasound-guided percutaneous intercostal cryoanalgesia for multiple weeks of analgesia following mastectomy: a case series. Korean J Anesthesiol. 2020 04; 73(2):163-168. Gabriel RA, Finneran JJ, Swisher MW, Said ET, Sztain JF, Khatibi B, Wallace AM, Hosseini A, Trescot AM, Ilfeld BM. PMID: 31475505; PMCID: PMC7113157.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. The Impact of Surgeons on the Likelihood of Mastectomy in Breast Cancer. Ann Surg. 2019 05; 269(5):951-958. Boero IJ, Paravati AJ, Hou J, Gillespie EF, Schoenbrunner A, Unkart J, Wallace AM, Einck JP, Mell LK, Murphy JD. PMID: 29465454.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    50. MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial. J Clin Oncol. 2020 04 01; 38(10):1059-1069. Chien AJ, Tripathy D, Albain KS, Symmans WF, Rugo HS, Melisko ME, Wallace AM, Schwab R, Helsten T, Forero-Torres A, Stringer-Reasor E, Ellis ED, Kaplan HG, Nanda R, Jaskowiak N, Murthy R, Godellas C, Boughey JC, Elias AD, Haley BB, Kemmer K, Isaacs C, Clark AS, Lang JE, Lu J, Korde L, Edmiston KK, Northfelt DW, Viscusi RK, Yee D, Perlmutter J, Hylton NM, Van't Veer LJ, DeMichele A, Wilson A, Peterson G, Buxton MB, Paoloni M, Clennell J, Berry S, Matthews JB, Steeg K, Singhrao R, Hirst GL, Sanil A, Yau C, Asare SM, Berry DA, Esserman LJ, I-SPY 2 Consortium. PMID: 32031889; PMCID: PMC7106976.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    51. Process of Care in Breast Reconstruction and the Impact of a Dual-Trained Surgeon. Ann Plast Surg. 2018 05; 80(5S Suppl 5):S288-S291. Herrick NL, Unkart JT, Reid CM, Li SS, Wallace AM. PMID: 29489535.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Positive Surgical Margins in the 10 Most Common Solid Cancers. Sci Rep. 2018 04 09; 8(1):5686. Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, Lippman SM, Messer K, Molinolo A, Murphy JD, Pang J, Sacco A, Tringale KR, Wallace A, Nguyen QT. PMID: 29632347; PMCID: PMC5890246.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    53. Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer. Breast J. 2018 07; 24(4):526-530. Unkart JT, Proudfoot J, Wallace AM. PMID: 29498443; PMCID: PMC6043364.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    54. Evidence-Based Performance Measures: Quality Metrics for the Care of Patients Undergoing Breast Reconstruction. Plast Reconstr Surg. 2017 Dec; 140(6):775e-781e. Manahan MA, Wooden WA, Becker SM, Cacioppo JR, Edge SB, Grandinetti AC, Gray DD, Holley SO, Karp NS, Kocak E, Rao R, Rosson GD, Schwartz JS, Sitzman TJ, Soltanian HT, TerKonda SP, Wallace AM. PMID: 29176411.
      View in: PubMed   Mentions: 2     Fields:    
    55. Erratum to: Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study. Ann Surg Oncol. 2017 12; 24(Suppl 3):693. Unkart JT, Chen SL, Wapnir IL, González JE, Harootunian A, Wallace AM. PMID: 28762115.
      View in: PubMed   Mentions: 1     Fields:    
    56. Use of 99mTc-Tilmanocept as a Single Agent for Sentinel Lymph Node Identification in Breast Cancer: A Retrospective Pilot Study. J Nucl Med Technol. 2017 Sep; 45(3):181-184. Unkart JT, Wallace AM. PMID: 28705929.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study. Ann Surg Oncol. 2017 Oct; 24(11):3167-3173. Unkart JT, Chen SL, Wapnir IL, González JE, Harootunian A, Wallace AM. PMID: 28699134.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    58. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial. J Surg Oncol. 2017 Dec; 116(7):819-823. Unkart JT, Hosseini A, Wallace AM. PMID: 28695567.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    59. Post-mastectomy cancer recurrence with and without a continuous paravertebral block in the immediate postoperative period: a prospective multi-year follow-up pilot study of a randomized, triple-masked, placebo-controlled investigation. J Anesth. 2017 Jun; 31(3):374-379. Finn DM, Ilfeld BM, Unkart JT, Madison SJ, Suresh PJ, Sandhu NPS, Kormylo NJ, Malhotra N, Loland VJ, Wallace MS, Wen CH, Morgan AC, Wallace AM. PMID: 28364165; PMCID: PMC5476449.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    60. Comparison of brain MRI findings with language and motor function in the dystroglycanopathies. Neurology. 2017 Feb 14; 88(7):623-629. Brun BN, Mockler SR, Laubscher KM, Stephan CM, Wallace AM, Collison JA, Zimmerman MB, Dobyns WB, Mathews KD. PMID: 28087826; PMCID: PMC5317381.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    61. Treatment of Post-Latissimus Dorsi Flap Breast Reconstruction Pain With Continuous Paravertebral Nerve Blocks: A Retrospective Review. Anesth Pain Med. 2016 Oct; 6(5):e39476. Unkart JT, Padwal JA, Ilfeld BM, Wallace AM. PMID: 27847703; PMCID: PMC5101420.
      View in: PubMed   Mentions: 7  
    62. Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer. N Engl J Med. 2016 Jul 07; 375(1):23-34. Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ, I-SPY 2 Investigators. PMID: 27406347; PMCID: PMC5259561.
      View in: PubMed   Mentions: 224     Fields:    Translation:HumansCTClinical Trials
    63. Adaptive Randomization of Neratinib in Early Breast Cancer. N Engl J Med. 2016 Jul 07; 375(1):11-22. Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA, I-SPY 2 Investigators. PMID: 27406346; PMCID: PMC5259558.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansCTClinical Trials
    64. Are self-identified "disadvantaged" students less likely to enter surgical residencies? A single-institution study. J Surg Res. 2016 05 15; 202(2):253-8. Unkart JT, Reid CM, Baumgartner JM, Wallace AM, Kelly CJ. PMID: 27229098.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Evaluation of Facial Volume Changes after Rejuvenation Surgery Using a 3-Dimensional Camera. Aesthet Surg J. 2016 Apr; 36(4):379-87. Mailey B, Baker JL, Hosseini A, Collins J, Suliman A, Wallace AM, Cohen SR. PMID: 26628536.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    66. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors. PLoS One. 2015; 10(11):e0142487. Bao L, Messer K, Schwab R, Harismendy O, Pu M, Crain B, Yost S, Frazer KA, Rana B, Hasteh F, Wallace A, Parker BA. PMID: 26554380; PMCID: PMC4640562.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    67. Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S559-65. Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, Wallace AM. PMID: 26275779; PMCID: PMC4686557.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    68. A window-of-opportunity biomarker study of etodolac in resectable breast cancer. Cancer Med. 2015 Oct; 4(10):1583-8. Schwab RB, Kato S, Crain B, Pu M, Messer K, Weidner N, Blair SL, Wallace AM, Carson DA, Parker BA. PMID: 26275572; PMCID: PMC4618628.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    69. Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):880-915. Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, Laronga C, Layman RM, Loftus LS, Mahoney MC, Merajver SD, Meszoely IM, Mortimer J, Newman L, Pritchard E, Pruthi S, Seewaldt V, Specht MC, Visvanathan K, Wallace A, Bergman MA, Kumar R. PMID: 26150582.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    70. Single-injection thoracic paravertebral block and postoperative analgesia after mastectomy: a retrospective cohort study. J Clin Anesth. 2015 Aug; 27(5):371-4. Agarwal RR, Wallace AM, Madison SJ, Morgan AC, Mascha EJ, Ilfeld BM. PMID: 25957529; PMCID: PMC4467997.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Persistent postmastectomy pain and pain-related physical and emotional functioning with and without a continuous paravertebral nerve block: a prospective 1-year follow-up assessment of a randomized, triple-masked, placebo-controlled study. Ann Surg Oncol. 2015; 22(6):2017-25. Ilfeld BM, Madison SJ, Suresh PJ, Sandhu NS, Kormylo NJ, Malhotra N, Loland VJ, Wallace MS, Mascha EJ, Xu Z, Wen CH, Morgan AC, Wallace AM. PMID: 25413267.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    72. Increased likelihood of mastectomy in human epidermal growth factor receptor 2-positive ductal carcinoma in situ. Am Surg. 2014 Oct; 80(10):936-9. Weiss A, Tran V, Baker J, Farnaz H, Wallace AM, Chang D, Ojeda-Fournier H, Blair SL. PMID: 25264633.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    73. Breast cancer in a RAD51D mutation carrier: case report and review of the literature. Clin Breast Cancer. 2015 Feb; 15(1):e71-5. Baker JL, Schwab RB, Wallace AM, Madlensky L. PMID: 25445424.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    74. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients. Ann Surg Oncol. 2015 Jan; 22(1):40-5. Baker JL, Pu M, Tokin CA, Hoh CK, Vera DR, Messer K, Wallace AM. PMID: 25069859; PMCID: PMC4273083.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    75. Fluorescent-tilmanocept for tumor margin analysis in the mouse model. J Surg Res. 2014 Aug; 190(2):528-34. Hosseini A, Baker JL, Tokin CA, Qin Z, Hall DJ, Stupak DG, Hayashi T, Wallace AM, Vera DR. PMID: 24923630; PMCID: PMC4201840.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    76. Treatment of postmastectomy pain with ambulatory continuous paravertebral nerve blocks: a randomized, triple-masked, placebo-controlled study. Reg Anesth Pain Med. 2014 Mar-Apr; 39(2):89-96. Ilfeld BM, Madison SJ, Suresh PJ, Sandhu NS, Kormylo NJ, Malhotra N, Loland VJ, Wallace MS, Proudfoot JA, Morgan AC, Wen CH, Wallace AM. PMID: 24448512; PMCID: PMC3944096.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    77. Abstract 131: Adipose Derived Stem Cell Count is Influenced by Receipt of Chemotherapy in Breast Cancer Patients. Plast Reconstr Surg. 2014 Mar; 133(3 Suppl):147. Mailey B, Baker J, Hosseini A, Alfonso Z, Strasser P, Hicok K, Cohen SR, Gosman A, Dobke M, Wallace AM. PMID: 25942242.
      View in: PubMed   Mentions: 1     Fields:    
    78. Adipose-derived stem cells: methods for isolation and applications for clinical use. Methods Mol Biol. 2014; 1210:161-81. Mailey B, Hosseini A, Baker J, Young A, Alfonso Z, Hicok K, Wallace AM, Cohen SR. PMID: 25173168.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    79. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Res. 2013 Dec 10; 15(6):R115. Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. PMID: 24326041; PMCID: PMC3978701.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    80. Single dual-trained surgeon for breast care leads to higher reconstruction rates after mastectomy. World J Surg. 2013 Nov; 37(11):2600-6. Shaterian A, Saba SC, Yee B, Tokin C, Mailey B, Dobke MK, Wallace AM. PMID: 23963349.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    81. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J Biomed Opt. 2013 Oct; 18(10):101315. Qin Z, Hall DJ, Liss MA, Hoh CK, Kane CJ, Wallace AM, Vera DR. PMID: 23958947; PMCID: PMC3745642.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    82. Postmastectomy reconstruction is associated with improved survival in patients with invasive breast cancer: a single-institution study. Am Surg. 2013 Oct; 79(10):977-81. Baker JL, Mailey B, Tokin CA, Blair SL, Wallace AM. PMID: 24160782.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    83. A comparison of cell-enriched fat transfer to conventional fat grafting after aesthetic procedures using a patient satisfaction survey. Ann Plast Surg. 2013 Apr; 70(4):410-5. Mailey B, Saba S, Baker J, Tokin C, Hickey S, Wong R, Wallace AM, Cohen SR. PMID: 23486128.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    84. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials. Ann Surg Oncol. 2013 Aug; 20(8):2590-9. Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR. PMID: 23504141; PMCID: PMC3705144.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    85. The pedicled myocutaneous flap as a choice reconstructive technique for immediate adjuvant brachytherapy in sarcoma treatment. Curr Oncol. 2012 Dec; 19(6):e491-5. Saba SC, Shaterian A, Tokin C, Dobke MK, Wallace AM. PMID: 23300372; PMCID: PMC3503679.
      View in: PubMed   Mentions: 5     Fields:    
    86. Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development. J Clin Oncol. 2012 Dec 20; 30(36):4584-6; author reply 4588-9. Yee D, Haddad T, Albain K, Barker A, Benz C, Boughey J, Buxton M, Chien AJ, DeMichele A, Dilts D, Elias A, Haluska P, Hogarth M, Hu A, Hytlon N, Kaplan HG, Kelloff GG, Khan Q, Lang J, Leyland-Jones B, Liu M, Nanda R, Northfelt D, Olopade OI, Park J, Parker B, Parkinson D, Pearson-White S, Perlmutter J, Pusztai L, Symmans F, Rugo H, Tripathy D, Wallace A, Wholley D, Van't Veer L, Berry DA, Esserman L. PMID: 23169510.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    87. Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol. 2013 Feb; 20(2):680-8. Sondak VK, King DW, Zager JS, Schneebaum S, Kim J, Leong SP, Faries MB, Averbook BJ, Martinez SR, Puleo CA, Messina JL, Christman L, Wallace AM. PMID: 23054107; PMCID: PMC3560941.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    88. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012 Oct; 265(1):186-93. Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane CJ, Wallace AM, Vera DR. PMID: 22753678; PMCID: PMC3447170.
      View in: PubMed   Mentions: 28     Fields:    Translation:Animals
    89. The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of care. Clin Exp Metastasis. 2012 Oct; 29(7):681-6. Tokin CA, Cope FO, Metz WL, Blue MS, Potter BM, Abbruzzese BC, Hartman RD, Joy MT, King DW, Christman LA, Vera DR, Wallace AM. PMID: 22729510.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    90. Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model. Clin Exp Metastasis. 2012 Oct; 29(7):673-80. Stroup SP, Kane CJ, Farchshchi-Heydari S, James CM, Davis CH, Wallace AM, Hoh CK, Vera DR. PMID: 22714690.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    91. Breast cancer presenting within or adjacent to the breast implant capsule: a case series and clinical recommendations. Clin Breast Cancer. 2012 Aug; 12(4):296-9. Tokin CA, Wallace AM. PMID: 22507305.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. Quantitative comparison of surgical margin histology following excision with traditional electrosurgery and a low-thermal-injury dissection device. J Surg Oncol. 2011 Dec; 104(7):746-54. Ruidiaz ME, Cortes-Mateos MJ, Sandoval S, Martin DT, Wang-Rodriguez J, Hasteh F, Wallace A, Vose JG, Kummel AC, Blair SL. PMID: 21744349.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    93. Initial clinical experience with the Strut-Adjusted Volume Implant (SAVI) breast brachytherapy device for accelerated partial-breast irradiation (APBI): first 100 patients with more than 1 year of follow-up. Int J Radiat Oncol Biol Phys. 2011 Jul 01; 80(3):765-70. Yashar CM, Scanderbeg D, Kuske R, Wallace A, Zannis V, Blair S, Grade E, Swenson VH, Quiet C. PMID: 20646847.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    94. Initial clinical experience with the Strut-Adjusted Volume Implant brachytherapy applicator for accelerated partial breast irradiation. Brachytherapy. 2009 Oct-Dec; 8(4):367-72. Yashar CM, Blair S, Wallace A, Scanderbeg D. PMID: 19744892.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    95. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. Nucl Med Biol. 2009 Aug; 36(6):687-92. Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera DR. PMID: 19647175; PMCID: PMC4201841.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    96. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. Nucl Med Biol. 2007 Oct; 34(7):849-53. Wallace AM, Hoh CK, Darrah DD, Schulteis G, Vera DR. PMID: 17921035; PMCID: PMC4189800.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    97. Bilaterally symmetric juvenile fibroadenomas and tubular breast deformity in a prepubescent girl. J Pediatr Surg. 2007 Jun; 42(6):1133-6. Moore RL, Mungara A, Shayan K, Wallace AM. PMID: 17560236.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    98. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol. 2007 Feb; 14(2):913-21. Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR. PMID: 17146742.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    99. The efficacy of breast MRI in predicting breast conservation therapy. J Surg Oncol. 2006 Sep 01; 94(3):220-5. Blair S, McElroy M, Middleton MS, Comstock C, Wolfson T, Kamrava M, Wallace A, Mortimer J. PMID: 16900536.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    100. Molecular targeting of the lymphovascular system for imaging and therapy. Cancer Metastasis Rev. 2006 Jun; 25(2):185-201. Schöder H, Glass EC, Pecking AP, Harness JK, Wallace AM, Hirnle P, Alberini JL, Vilain D, Larson SM, Hoh CK, Vera DR. PMID: 16770532.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCTClinical Trials
    101. Minimally invasive sentinel lymph node mapping of the pig colon with Lymphoseek. Surgery. 2006 Feb; 139(2):217-23. Wallace AM, Ellner SJ, Méndez J, Hoh CK, Salem CE, Bosch CM, Orahood RC, Vera DR. PMID: 16455331.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    102. A preclinical study of prostate sentinel lymph node mapping with [99mTC]diethylenetetramine pentaacetic acid-mannosyl-dextran. J Urol. 2006 Feb; 175(2):744-8. Salem CE, Hoh CK, Wallace AM, Vera DR. PMID: 16407043.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    103. Breast imaging: a surgeon's prospective. Nucl Med Biol. 2005 Oct; 32(7):781-92. Wallace AM, Comstock C, Hoh CK, Vera DR. PMID: 16243654.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    104. IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1. Oncogene. 2005 Jul 07; 24(29):4624-33. Fung MM, Chu YL, Fink JL, Wallace A, McGuire KL. PMID: 15735688.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    105. Sentinel lymph node mapping of the colon and stomach using lymphoseek in a pig model. Ann Surg Oncol. 2004 Jul; 11(7):674-81. Ellner SJ, Méndez J, Vera DR, Hoh CK, Ashburn WL, Wallace AM. PMID: 15231522.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    106. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping. Nucl Med Biol. 2003 Nov; 30(8):805-10. Ellner SJ, Hoh CK, Vera DR, Darrah DD, Schulteis G, Wallace AM. PMID: 14698783.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    107. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs. J Nucl Med. 2003 Oct; 44(10):1677-81. Méndez J, Wallace AM, Hoh CK, Vera DR. PMID: 14530486.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    108. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran . Nucl Med Biol. 2003 Jul; 30(5):457-64. Hoh CK, Wallace AM, Vera DR. PMID: 12831982.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    109. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol. 2003 Jun; 10(5):531-8. Wallace AM, Hoh CK, Vera DR, Darrah DD, Schulteis G. PMID: 12794019.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCellsCTClinical Trials
    110. The role of sentinel lymph node biopsy for melanoma. Semin Oncol. 2002 Aug; 29(4):341-52. Shen J, Wallace AM, Bouvet M. PMID: 12170437.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    111. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J Clin Oncol. 2002 Feb 15; 20(4):1075-86. Mitchell MS, Darrah D, Yeung D, Halpern S, Wallace A, Voland J, Jones V, Kan-Mitchell J. PMID: 11844833.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials
    112. Ras activation in human breast cancer. Breast Cancer Res Treat. 2000 Jul; 62(1):51-62. von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR. PMID: 10989985.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    113. Pain after breast surgery: a survey of 282 women. Pain. 1996 Aug; 66(2-3):195-205. Wallace MS, Wallace AM, Lee J, Dobke MK. PMID: 8880841.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCTClinical Trials
    114. Unexpected vascular compromise in transverse rectus abdominis musculocutaneous (TRAM) flap reconstruction: a report of two patients. Ann Plast Surg. 1996 Mar; 36(3):246-50. Wallace AM, Evans GR, Goldberg DP, Baldwin BJ. PMID: 8659946.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Anne's Networks
    Concepts (372)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (119)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California